BPBT
PRTA icon

Boston Private Bank & Trust’s Prothena Corp PRTA Stock Holding History

Boston Private Bank & Trust’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1
Closed – – 1069
2013
Q4 		$0 Buy
+1
New +$25 ﹤0.01% 1075
2013
Q3 		– Sell
-31
Closed – – 998
2013
Q2 		$0 Buy
+31
New +$288 ﹤0.01% 948

Other funds holding PRTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Private Bank & Trust's PRTA Position: Q1 2014 in Review

Boston Private Bank & Trust sold out of Prothena Corp (PRTA) in Q1 2014, closing a stake of 1 share.

Boston Private Bank & Trust first reported a position in PRTA in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q4 2013. 118 funds tracked by Wall St. Rank hold PRTA as of Q1 2014.

  • Boston Private Bank & Trust reported no remaining Prothena Corp position as of Q1 2014 after selling out during the quarter.
  • Boston Private Bank & Trust sold 1 Prothena Corp share in Q1 2014.
  • Boston Private Bank & Trust first reported a position in Prothena Corp in Q2 2013 and held it in 2 quarters.
  • Boston Private Bank & Trust's Prothena Corp position peaked at $0 in Q4 2013.
  • 118 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2014.

Based on Boston Private Bank & Trust's 13F filing for Q1 2014, filed 15 Apr 2014.